Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.425 USD | -6.51% | -12.22% | +37.86% |
05-15 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
05-14 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.86% | 45.72M | |
+70.03% | 62.86B | |
-0.78% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.28% | 26.46B | |
-22.46% | 18.9B | |
+4.85% | 12.67B | |
+24.11% | 12.27B | |
+28.09% | 12.07B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Transcript : Daré Bioscience, Inc., Q2 2021 Earnings Call, Aug 12, 2021